About the Corporate Council
The ACAAI Corporate Council offers companies exposure to nearly 6,000 allergists and immunologists, including more than 3,000 who are board-certified by the ABAI. Participation in the Corporate Council also provides valuable access to the ACAAI Board of Regents and other key opinion leaders.
The Corporate Council is comprised of senior executives from pharmaceutical, medical device and other companies involved in the field of allergy and immunology. Two representatives from each participating company will hold seats on the Corporate Council and will be invited to the annual Corporate Council roundtable meeting.
The Council’s goal is to address critical issues in allergy and immunology, find solutions to pressing challenges, share knowledge of best practices and advise members on upcoming initiatives. By pooling resources and expertise, Corporate Council members and the ACAAI leadership can engage in joint problem-solving and explore collaborative opportunities to improve patient care and advance the mission of ACAAI.
To learn more about becoming a member of the ACAAI Corporate Council, please contact:
Linda Cullison
Director of Corporate Relations
American College of Allergy, Asthma & Immunology
Phone: 847-725-2291
Email: lindacullison@acaai.org
Partners
Amgen
One Amgen Center Drive
Thousand Oaks, CA
91320-1799
https://www.amgen.com/
AstraZeneca
1800 Concord Pike
Wilmington, DE 19850
Tel: 800-236-9933
Tel: 877-810-6060
www.astrazeneca-us.com
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit www.astrazeneca-us.com.
Blueprint Medicines
45 Sidney Street
Cambridge, MA 02139
Tel: (617) 374-7580
www.blueprintmedicines.com
Blueprint Medicines is a global precision therapy company that aims to invent life-changing medicines. Applying an approach that is both precise and agile, we seek to create therapies that selectively target the root cause of disease, with the goal of staying one step ahead across stages of disease.
A core component of our company strategy is extending our leadership position in Systemic Mastocytosis (SM) and expanding it to other mast cell disorders.
We are leveraging our deep understanding of disease biology to drive scientific innovation and then bringing that innovation to patients with our clinical and regulatory know-how. Today, we have brought our approved medicines to patients in the United States and Europe, and we are globally advancing multiple programs for mast cell disorders, including systemic mastocytosis and chronic urticaria as well as breast cancer and other solid tumors.
For more information, visit https://www.blueprintmedicines.com/medical-professionals/
Bryn Pharma, LLC
www.brynpharma.com
Bryn Pharma, LLC is a pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis. Bryn was founded by patients who are personally affected by anaphylaxis. The concerns of patients and caregivers, like us, have informed our approach. Our experience has fueled our drive to find A Better Way.
Our mission is simple: to develop a needle-free epinephrine nasal spray that is clinically comparable to the current standard of care (the epinephrine autoinjector), small enough to comfortably carry in a pocket, and easy to use without specialized medical training.
Bryn is focused on supporting the needs of patients, caregivers, and healthcare professionals in delivering an easy-to-use alternative to autoinjectors that will make a meaningful difference in patients’ willingness to carry and use their epinephrine when they need it.
For more information about Bryn Pharma, please visit us at www.brynpharma.com.
Chiesi USA, Inc.
175 Regency Woods Place, Ste. 600
Cary, NC 27518
https://www.chiesiusa.com/
DBV Technologies
25 DeForest Avenue, Suite 203
Summit, NJ 07901
www.dbv-technologies.com
Dermavant Sciences, Inc.
3780 Kilroy Airport Way, Suite 250
Long Beach, CA 90806
https://www.dermavant.com/
DERMAVANT. Innovating. Pioneering. Transforming.
Dermavant is committed to fostering unprecedented change and unparalleled impact in immunodermatology. We’re doing this by thinking differently, pushing the boundaries of science and partnering with providers in new ways — all with one goal: Improving the lives of millions of patients with skin diseases.
Learn more about who we are and the product candidates we’re developing at >Dermavant.com
Please contact medinfo@dermavant.com with any inquiries.
Genentech
1 DNA Way
South San Francisco, CA 94080
www.gene.com
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California.
GSK
Five Moore Drive
Research Triangle Park, NC 27709
us.gsk.com/en-us/home/
GSK is a science-led global healthcare company with a special purpose: to help people. We research, develop and manufacture innovative pharmaceutical, biological, vaccine, and consumer healthcare products in an effort to bring differentiated, high-quality products, resources, and the science behind it all.
Incyte Corporation
1801 Augustine Cut-Off
Wilmington, DE 19803
www.incyte.com
Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad, CA 92010
https://www.ionispharma.com/
For three decades, Ionis Pharmaceuticals has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionispharma.com and follow us on X (Twitter) and LinkedIn.
KalVista Pharmceuticals
55 Cambridge Parkway
Suite 901E
Cambridge, MA 02142
https://www.kalvista.com/
Merck & Co., Inc.
351 North Sumneytown Pike
North Wales, PA 19454
www.merck.com
Novartis Pharmaceuticals Corporation
One Health Plaza
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world. Follow us at https://www.novartis.com, also on Twitter, Facebook and LinkedIn
Pfizer, Inc.
235 East 42nd Street
New York, NY 10017, USA
www.pfizer.com
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.
Pharming Healthcare, Inc.
685 Route 202/206, Suite 202
Bridgewater, NJ 08807
Tel: 800-930-5221
www.pharming.com
Pharming Healthcare, Inc. is dedicated to providing life-changing solutions to patients. Pharming is currently involved in the development of drugs for the treatment of hereditary angioedema and has marketing operations in the United States, Israel, all 28 European Union countries plus Norway, Iceland, and Liechtenstein.
Sanofi US
55 Corporate Drive
Bridgewater, NJ 08807
www.sanofi.us/en
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill Road
Tarrytown, NY 10591-6707
www.regeneron.com
Since 2007, Sanofi and Regeneron have collaborated to help people with conditions that are often difficult to diagnose and treat, using innovative technology platforms. Sanofi is an innovative global healthcare company that provides potentially life-changing treatment options and life-saving vaccine protection to millions of people globally. Regeneron is a leading science-based biopharmaceutical company that invents, develops and commercializes medicines to treat serious medical conditions.
Stallergenes Greer
639 Nuway Circle
Lenoir, NC 28645
www.stallergenesgreerus.com
Headquartered in North Carolina, Stallergenes Greer’s business in the United States is part of a leading global biopharmaceutical company specializing in the development and commercialization of allergy immunotherapy (AIT) products and services for use in the diagnosis and treatment of allergies.
Takeda Pharmaceutical Company Limited
650 Kendall Street
Cambridge, MA 02142
www.takeda.com
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries. For more information, visit www.takeda.com.
